跳转至内容
Merck
CN
  • Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A.

Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A.

Cell stem cell (2019-08-03)
Fabian L Cardenas-Diaz, Catherine Osorio-Quintero, Maria A Diaz-Miranda, Siddharth Kishore, Karla Leavens, Chintan Jobaliya, Diana Stanescu, Xilma Ortiz-Gonzalez, Christine Yoon, Christopher S Chen, Rachana Haliyur, Marcela Brissova, Alvin C Powers, Deborah L French, Paul Gadue
摘要

Human monogenic diabetes, caused by mutations in genes involved in beta cell development and function, has been a challenge to study because multiple mouse models have not fully recapitulated the human disease. Here, we use genome edited human embryonic stem cells to understand the most common form of monogenic diabetes, MODY3, caused by mutations in the transcription factor HNF1A. We found that HNF1A is necessary to repress an alpha cell gene expression signature, maintain endocrine cell function, and regulate cellular metabolism. In addition, we identified the human-specific long non-coding RNA, LINKA, as an HNF1A target necessary for normal mitochondrial respiration. These findings provide a possible explanation for the species difference in disease phenotypes observed with HNF1A mutations and offer mechanistic insights into how the HNF1A gene may also influence type 2 diabetes.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
N-乙酰基-L-半胱氨酸, BioReagent, suitable for cell culture
Sigma-Aldrich
SANT-1 型, ≥98% (HPLC), powder
Sigma-Aldrich
γ分泌酶抑制剂 XX, This γ-secretase inhibitor, CAS 209984-56-5, is a cell-permeable dibenzazepine compound that lowers both brain and plasma Aβ40 levels by ~72% in Tg2576 mutant APP transgenic mouse model.